Molina describes utility of 6 TM (including NSE, which we excluded due to lack of a Roche assay) in 3144 consecutive individuals referred by their primary care physician because of the clinical suspicion of lung cancer (of which 1828 were confirmed as cases, 58%). Here, ENO2 is linked to lung cancer.